Role of Tyr356(7.43) and Ser190(4.57) in Antagonist Binding in the Rat β1-Adrenergic Receptor

Journal of Medicinal Chemistry
2006.0

Abstract

Site-directed mutagenesis and photoaffinity labeling experiments suggest the existence of at least two distinct binding orientations for aryloxypropanolamine competitive antagonists in the beta-adrenergic receptor (beta-AR), one where the aryloxy moiety is located near transmembrane alpha-helix 7 (tm 7) and another where it is near tm 5. To explore a hydrophobic pocket involving tms 1, 2, 3, and 7 for potential aryloxy interaction sites, we selected Tyr(356(7.43)) and Trp(134(3.28)) in the rat beta(1)-AR for site-directed mutagenesis studies. Ser(190(4.57)) was also investigated, as the equivalent residues are known antagonist interaction sites in the muscarinic M(1) and the dopamine D(2) receptors. Binding affinities (pK(i)) of a series of structurally diverse aryloxypropanolamine competitive antagonists were determined for wild type and Y356A, Y356F, W134A, and S190A mutant rat beta(1)-ARs stably expressed in Chinese hamster ovary cells. To visualize possible antagonist/receptor interactions, the compounds were docked into a three-dimensional model of the wild-type rat beta(1)-AR. The results indicate that Tyr(356(7.43)) is an important aromatic interaction site for five of the eight competitive antagonists studied, whereas none of the compounds appeared to interact directly with Trp(134(3.28)). Only two of the competitive antagonists interacted with Ser(190(4.57)) on tm 4. Overall, the results extend our understanding of how beta(1)-AR competitive antagonists bind to the hydrophobic pocket involving tms 1, 2, 3, and 7; highlight the importance of Tyr(356(7.43)) in this binding pocket; and demonstrate the involvement of tm 4 in competitive antagonist binding.

Knowledge Graph

Similar Paper

Role of Tyr<sup>356(7.43)</sup> and Ser<sup>190(4.57)</sup> in Antagonist Binding in the Rat β<sub>1</sub>-Adrenergic Receptor
Journal of Medicinal Chemistry 2006.0
Structural basis of the selectivity of the β2-adrenergic receptor for fluorinated catecholamines
Bioorganic &amp; Medicinal Chemistry 2009.0
Mutagenesis Reveals Structure−Activity Parallels between Human A<sub>2A</sub>Adenosine Receptors and Biogenic Amine G Protein-Coupled Receptors
Journal of Medicinal Chemistry 1997.0
Computer-aided mapping of the .beta.-adrenoceptor I: Explanation for effect of para substitution on blocking activity at the .beta.-1-adrenoceptor
Journal of Medicinal Chemistry 1992.0
A comprehensive study on the 5-hydroxytryptamine3A receptor binding of agonists serotonin and m-chlorophenylbiguanidine
Bioorganic &amp; Medicinal Chemistry 2009.0
An Aromatic Microdomain at the Cannabinoid CB<sub>1</sub> Receptor Constitutes an Agonist/Inverse Agonist Binding Region
Journal of Medicinal Chemistry 2003.0
α<sub>2</sub>-Adrenoreceptors Profile Modulation. 4. From Antagonist to Agonist Behavior
Journal of Medicinal Chemistry 2008.0
.beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines
Journal of Medicinal Chemistry 1983.0
Exploring the Determinants of Trace Amine-Associated Receptor 1’s Functional Selectivity for the Stereoisomers of Amphetamine and Methamphetamine
Journal of Medicinal Chemistry 2014.0
Design and synthesis of propranolol analogs as serotonergic agents
Journal of Medicinal Chemistry 1989.0